Patents Represented by Attorney Ryan W. Cagle
  • Patent number: 8278109
    Abstract: The present invention related to a pregnancy test device that can selectively detect hyperglycosylated human chorionic gonadotropin (hCG-H) in a liquid sample. The sample can be deposited on a proximal portion of the device for transport to a distal portion of the device. The device can include a release medium formed of a first material and including a detectable label thereon and a capture medium, including a capture site, in fluid communication with the release medium and formed of a second, different material. At least one of the release medium and the capture medium includes a binding member that exhibits a moderate to high affinity for hCG-H and is selectively or preferentially reactive with hCG-H.
    Type: Grant
    Filed: February 12, 2010
    Date of Patent: October 2, 2012
    Assignee: Church & Dwight Co., Inc.
    Inventors: Albert R. Nazareth, Timothy Snowden
  • Patent number: 8268636
    Abstract: The invention comprises a device for detecting an analyte in a liquid sample deposited on a first portion of the device for transport to a second portion of the device that is in fluid contact with the first portion. In specific embodiments, the device comprises a labeled conjugate comprising a binding member reactive with a first epitope of the analyte and a label comprising a gold colloid, preferably having a mean particle size of 50 nm to 100 nm. In further embodiments, the device comprises a capture component comprising polymerized streptavidin. The diagnostic device is particularly useful in the preparation of pregnancy test kits.
    Type: Grant
    Filed: June 25, 2010
    Date of Patent: September 18, 2012
    Assignee: Church & Dwight Co., Inc.
    Inventors: Albert Nazareth, Timothy Snowden, Yea-shun Cheng
  • Patent number: 8211711
    Abstract: The invention comprises a device for detecting an analyte in a liquid sample deposited on a first portion of the device for transport to a second portion of the device that is in fluid contact with the first portion. In specific embodiments, the device comprises a labeled conjugate comprising a binding member reactive with a first epitope of the analyte and a label comprising a gold colloid, preferably having a mean particle size of 50 nm to 100 nm. In further embodiments, the device comprises a capture component comprising polymerized streptavidin. The diagnostic device is particularly useful in the preparation of pregnancy test kits.
    Type: Grant
    Filed: June 25, 2010
    Date of Patent: July 3, 2012
    Assignee: Church & Dwight Co., Inc.
    Inventors: Albert Nazareth, Timothy Snowden, Yea-shun Cheng
  • Patent number: 7776618
    Abstract: The invention comprises a device for detecting an analyte in a liquid sample deposited on a first portion of the device for transport to a second portion of the device that is in fluid contact with the first portion. In specific embodiments, the device comprises a labeled conjugate comprising a binding member reactive with a first epitope of the analyte and a label comprising a gold colloid, preferably having a mean particle size of 50 nm to 100 nm. In further embodiments, the device comprises a capture component comprising polymerized streptavidin. The diagnostic device is particularly useful in the preparation of pregnancy test kits.
    Type: Grant
    Filed: March 1, 2007
    Date of Patent: August 17, 2010
    Assignee: Church & Dwight Co., Inc.
    Inventors: Albert Nazareth, Timothy Snowden, Yea-shun Cheng